These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8074338)
1. [Current aspects of long-term corticotherapy in the elderly. The example of Horton disease]. Barrier JH; Magadur-Joly G Ann Med Interne (Paris); 1994 Jun; 145 Suppl 2():29-33. PubMed ID: 8074338 [No Abstract] [Full Text] [Related]
2. Treatment of giant cell arteritis. Barrier JH Ann Med Interne (Paris); 1994; 145(8):533-7. PubMed ID: 7710179 [No Abstract] [Full Text] [Related]
3. [Giant-cell arteritis with initial resistance to corticosteroids (author's transl)]. Treves R; Gerbaud A; Catanzano G; Desproges-Gotteron R Sem Hop; 1982 Jan; 58(1):13-5. PubMed ID: 6275541 [TBL] [Abstract][Full Text] [Related]
5. [Are corticoids the only alternative in the treatment of giant cell arteritis?]. Edgren B; Flood A; Nyberg AB Lakartidningen; 1980 Sep; 77(39):3390-1. PubMed ID: 7453342 [No Abstract] [Full Text] [Related]
6. [Giant cell arteritis: therapeutic perspectives]. Costa Roma J; Bella Cueto F Med Clin (Barc); 1985 Jun; 85(2):61-2. PubMed ID: 4021615 [No Abstract] [Full Text] [Related]
7. [Giant cell arteritis: clinical study and iatrogenesis by corticoids in 45 patients]. Carratalá J; Dorca E; Bolao F; Mañá J; Niubó R; Fernández Nogués F Rev Clin Esp; 1988 Jan; 182(1):22-5. PubMed ID: 3375510 [No Abstract] [Full Text] [Related]
8. [Early cerebral vascular accidents in treated Horton's disease. Responsibility of the corticoid treatment?]. Jouquan J; Mottier D; Cleuziou A; Pennec Y; Baccino E; Bergeret G; Garo B Ann Med Interne (Paris); 1984; 135(7):526-9. PubMed ID: 6517424 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of Horton's disease. Which modalities for corticotherapy?]. Liozon F Ann Med Interne (Paris); 1992; 143(2):83-4. PubMed ID: 1530224 [No Abstract] [Full Text] [Related]
11. [Kaposi sarcoma following treatment of giant cell arteritis with corticoids]. Pérez-Pascual JJ; Pérez-Mur J; Casanova JM; Egido R Med Clin (Barc); 1992 Dec; 99(20):793. PubMed ID: 1460953 [No Abstract] [Full Text] [Related]
13. [Cerebrovascular accidents in Horton's disease. Apropos of a case]. Tougourti MN; Sioud M; Hamza M Tunis Med; 1995 May; 73(5):195-9. PubMed ID: 9507283 [No Abstract] [Full Text] [Related]
14. [Corticosteroid saving-up in giant cell arteritis?]. Schnabel A Dtsch Med Wochenschr; 2002 Sep; 127(37):1910. PubMed ID: 12226792 [No Abstract] [Full Text] [Related]
15. [Atypical aspects of Horton's disease]. Maalej F; Kanoun F; Ben Djemaâ M; Ben Hamed S Tunis Med; 1996 Jan; 74(1):39-43. PubMed ID: 9507312 [No Abstract] [Full Text] [Related]
16. [Clinical aspects and diagnosis of temporal arteritis]. Semenkova EN; Taranova MV Ter Arkh; 1984; 56(8):127-9. PubMed ID: 6495193 [No Abstract] [Full Text] [Related]
17. [Anticardiolipin antibodies and Horton disease]. Liozon F; Jauberteau-Marchan MO; Boutros-Toni F; Barrier JH; Dupond JL; Roblot P; Liozon E; Delaire L; Vidal E Ann Med Interne (Paris); 1995; 146(8):541-7. PubMed ID: 8734078 [TBL] [Abstract][Full Text] [Related]
18. [Start treatment of temporalis arteritis immediately--otherwise your patient might become blind!]. Myllykangas-Luosujärvi R Duodecim; 1998; 114(21):2183-5. PubMed ID: 11757106 [No Abstract] [Full Text] [Related]
19. [Temporal arteritis. A prospective study with special reference to the course of the disease]. Fjermestad T Tidsskr Nor Laegeforen; 1983 Feb; 103(6):595-6. PubMed ID: 6868034 [No Abstract] [Full Text] [Related]